These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 33369138)
1. The anti-angiogenesis role of FBXW7 in diabetic retinopathy by facilitating the ubiquitination degradation of c-Myc to orchestrate the HDAC2. Hu L; Lv X; Li D; Zhang W; Ran G; Li Q; Hu J J Cell Mol Med; 2021 Feb; 25(4):2190-2202. PubMed ID: 33369138 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of histone deacetylase SIRT1 exerts an antiangiogenic role in diabetic retinopathy via miR-20a elevation and YAP/HIF1α/VEGFA depletion. Pan Q; Gao Z; Zhu C; Peng Z; Song M; Li L Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E932-E943. PubMed ID: 32776826 [TBL] [Abstract][Full Text] [Related]
3. F-box and WD repeat domain-containing 7 (FBXW7) mediates the hypoxia inducible factor-1α (HIF-1α)/vascular endothelial growth factor (VEGF) signaling pathway to affect hypoxic-ischemic brain damage in neonatal rats. Sun L Bioengineered; 2022 Jan; 13(1):560-572. PubMed ID: 34951343 [TBL] [Abstract][Full Text] [Related]
4. MiR-203a-3p inhibits retinal angiogenesis and alleviates proliferative diabetic retinopathy in oxygen-induced retinopathy (OIR) rat model via targeting VEGFA and HIF-1α. Han N; Xu H; Yu N; Wu Y; Yu L Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):85-94. PubMed ID: 31408201 [TBL] [Abstract][Full Text] [Related]
5. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor. Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809 [TBL] [Abstract][Full Text] [Related]
6. Knockdown of Malat1 alleviates high-glucose-induced angiogenesis through regulating miR-205-5p/VEGF-A axis. Tan A; Li T; Ruan L; Yang J; Luo Y; Li L; Wu X Exp Eye Res; 2021 Jun; 207():108585. PubMed ID: 33887222 [TBL] [Abstract][Full Text] [Related]
7. Circular RNA COL1A2 promotes angiogenesis via regulating miR-29b/VEGF axis in diabetic retinopathy. Zou J; Liu KC; Wang WP; Xu Y Life Sci; 2020 Sep; 256():117888. PubMed ID: 32497630 [TBL] [Abstract][Full Text] [Related]
8. Down-Regulation of circCOL1A2 Suppresses the Dysfunction of Diabetes-Related Retinal Microvascular Endothelial Cells via miR-646/FGF7 Axis. Cao H; Xu X; Wang K; Li C Curr Eye Res; 2022 Nov; 47(11):1525-1533. PubMed ID: 35924466 [TBL] [Abstract][Full Text] [Related]
9. Chlorogenic acid attenuates diabetic retinopathy by reducing VEGF expression and inhibiting VEGF-mediated retinal neoangiogenesis. Mei X; Zhou L; Zhang T; Lu B; Sheng Y; Ji L Vascul Pharmacol; 2018 Feb; 101():29-37. PubMed ID: 29146180 [TBL] [Abstract][Full Text] [Related]
10. LncRNA-MALAT1 promotes neovascularization in diabetic retinopathy through regulating miR-125b/VE-cadherin axis. Liu P; Jia SB; Shi JM; Li WJ; Tang LS; Zhu XH; Tong P Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988072 [No Abstract] [Full Text] [Related]
11. Preliminary research on LncRNA ATP2B2-IT2 in neovascularization of diabetic retinopathy. Yuan Y; Zhu A; Zeng L; Wang X; Zhang Y; Long X; Wu J; Ye M; He J; Tan W BMC Ophthalmol; 2024 Jun; 24(1):267. PubMed ID: 38907191 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-199a-3p inhibits angiogenesis by targeting the VEGF/PI3K/AKT signalling pathway in an in vitro model of diabetic retinopathy. Wang L; Liu WX; Huang XG Exp Mol Pathol; 2020 Oct; 116():104488. PubMed ID: 32622012 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-409-5p promotes retinal neovascularization in diabetic retinopathy. Wang Y; Lin W; Ju J Cell Cycle; 2020 Jun; 19(11):1314-1325. PubMed ID: 32292119 [TBL] [Abstract][Full Text] [Related]
14. ARMCX1 inhibits lung adenocarcinoma progression by recruiting FBXW7 for c-Myc degradation. Hu Z; Wu Y; Sun X; Tong Y; Qiu H; Zhuo E Biol Direct; 2024 Sep; 19(1):82. PubMed ID: 39285446 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of Hypoxia-Induced Retinal Angiogenesis by Specnuezhenide, an Effective Constituent of Ligustrum lucidum Ait., through Suppression of the HIF-1α/VEGF Signaling Pathway. Wu J; Ke X; Fu W; Gao X; Zhang H; Wang W; Ma N; Zhao M; Hao X; Zhang Z Molecules; 2016 Dec; 21(12):. PubMed ID: 28009852 [TBL] [Abstract][Full Text] [Related]
16. miR-126 Mimic Counteracts the Increased Secretion of VEGF-A Induced by High Glucose in ARPE-19 Cells. Sanguineti R; Puddu A; Nicolò M; Traverso CE; Cordera R; Viviani GL; Maggi D J Diabetes Res; 2021; 2021():6649222. PubMed ID: 33709000 [TBL] [Abstract][Full Text] [Related]
17. RANBP10 promotes glioblastoma progression by regulating the FBXW7/c-Myc pathway. Hou J; Liu Y; Huang P; Wang Y; Pei D; Tan R; Zhang Y; Cui H Cell Death Dis; 2021 Oct; 12(11):967. PubMed ID: 34671019 [TBL] [Abstract][Full Text] [Related]
18. Berberis dictyophylla F. inhibits angiogenesis and apoptosis of diabetic retinopathy via suppressing HIF-1α/VEGF/DLL-4/Notch-1 pathway. Ai X; Yu P; Luo L; Sun J; Tao H; Wang X; Meng X J Ethnopharmacol; 2022 Oct; 296():115453. PubMed ID: 35697191 [TBL] [Abstract][Full Text] [Related]
19. Gambogic acid ameliorates diabetes-induced proliferative retinopathy through inhibition of the HIF-1α/VEGF expression via targeting PI3K/AKT pathway. Cui J; Gong R; Hu S; Cai L; Chen L Life Sci; 2018 Jan; 192():293-303. PubMed ID: 29129773 [TBL] [Abstract][Full Text] [Related]
20. A novel transthyretin/STAT4/miR-223-3p/FBXW7 signaling pathway affects neovascularization in diabetic retinopathy. Shao J; Fan G; Yin X; Gu Y; Wang X; Xin Y; Yao Y Mol Cell Endocrinol; 2019 Dec; 498():110541. PubMed ID: 31415795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]